Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

U.S. FDA considers approving a second COVID-19 booster shot -WSJ

Stock Markets Feb 19, 2022 05:55PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. FILE PHOTO: A worker from Chicago Family Health Center prepares a booster shot for the coronavirus disease (COVID-19) at a McDonald's, as the Omicron coronavirus variant spreads through the country, in Chicago, Illinois, U.S., December 21, 2021. REUTERS/J

(Reuters) -U.S. health regulators are looking at authorizing a potential fourth dose of a COVID-19 vaccine in the fall, the Wall Street Journal reported on Saturday, citing sources familiar with the matter.

The Food and Drug Administration has been reviewing data to authorize a second booster dose of the messenger RNA vaccines from Pfizer Inc (NYSE:PFE) and partner BioNTech SE (NASDAQ:BNTX) and vaccines from Moderna (NASDAQ:MRNA) Inc, the report added.

The FDA did not immediately respond to a request for comment.

The agency last month cut the interval to get a booster dose of COVID-19 vaccines from Pfizer and BioNTech as well as from Moderna, in a bid to provide better protection sooner against the Omicron variant.

The planning is still in early stages, and authorization would depend on determinations as to whether the second booster should be authorized for all adults or particular age groups, and whether it should target the Omicron variant or be formulated differently, the report said.

It added that no decision was final and that it could be necessary to make booster shots available earlier if a new variant appears.

The United States reported 2,323 COVID-19 deaths on Friday, bringing the total count to 936,523.

U.S. FDA considers approving a second COVID-19 booster shot -WSJ
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (15)
Lewis Dorta
Lewis Dorta Feb 19, 2022 9:21PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
the rescue
Lewis Dorta
Lewis Dorta Feb 19, 2022 9:21PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
covaxin
NAGARAJAN MUNUSAMY
NAGARAJAN MUNUSAMY Feb 19, 2022 6:48PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Ocugen and Bharat Biotech to Co-Develop BBV152, known as COVAXIN™ candidate outside of the U.S., a Whole-Virion Inactivated COVID-19 Vaccine, for the US Market.
NAGARAJAN MUNUSAMY
NAGARAJAN MUNUSAMY Feb 19, 2022 6:43PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
covaxin
NAGARAJAN MUNUSAMY
NAGARAJAN MUNUSAMY Feb 19, 2022 6:43PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
oxugen👍👍👍
Miles Mathewson
Miles Mathewson Feb 19, 2022 6:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
lol you gottta be kiddin me...how many doses more so these companies can keep profiting and we being injected with God knows what?
Gershom Zvi
Gershom Zvi Feb 19, 2022 5:36PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Wow I just imagine just year 2025 next 55th booster approved
Mike Blade
Mike Blade Feb 19, 2022 3:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Take NAC supplements to neutralize mrna vax.
Matt Biro
Matt Biro Feb 19, 2022 3:14PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Just one more booster and we can beat this thing goy- I mean guys.
Emmanouil Topouzoglou
Emmanouil Topouzoglou Feb 19, 2022 2:05PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
No jab no mask no tests, no ill since 2019
Martino Razz
Martino Razz Feb 19, 2022 2:05PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
that makes you a racist, brother. Welcome to 2022.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email